summary,PseudoDualSimulations-method | R Documentation |
Summary for Pseudo Dual responses simulations, relative to a given pseudo DLE and efficacy model (except the EffFlexi class model)
## S4 method for signature 'PseudoDualSimulations'
summary(
object,
trueDLE,
trueEff,
targetEndOfTrial = 0.3,
targetDuringTrial = 0.35,
...
)
object |
the |
trueDLE |
a function which takes as input a dose (vector) and returns the true probability (vector) of DLE |
trueEff |
a function which takes as input a dose (vector) and returns the mean efficacy value(s) (vector). |
targetEndOfTrial |
the target probability of DLE that are used at the end of a trial. Default at 0.3. |
targetDuringTrial |
the target probability of DLE that are used during the trial. Default at 0.35. |
... |
Additional arguments can be supplied here for |
an object of class PseudoDualSimulationsSummary
##obtain the plot for the simulation results
##If DLE and efficacy responses are considered in the simulations
##Specified your simulations when no samples are used
data <- DataDual(doseGrid=seq(25,300,25))
##First for the DLE model
##The DLE model must be of 'ModelTox' (e.g 'LogisticIndepBeta') class
DLEmodel <- LogisticIndepBeta(binDLE=c(1.05,1.8),
DLEweights=c(3,3),
DLEdose=c(25,300),
data=data)
##The efficacy model of 'ModelEff' (e.g 'Effloglog') class
Effmodel<-Effloglog(Eff=c(1.223,2.513),Effdose=c(25,300),
nu=c(a=1,b=0.025),data=data)
##The escalation rule using the 'NextBestMaxGain' class
mynextbest<-NextBestMaxGain(DLEDuringTrialtarget=0.35,
DLEEndOfTrialtarget=0.3)
##The increments (see Increments class examples)
## 200% allowable increase for dose below 300 and 200% increase for dose above 300
myIncrements<-IncrementsRelative(intervals=c(25,300),
increments=c(2,2))
##cohort size of 3
mySize<-CohortSizeConst(size=3)
##Stop only when 36 subjects are treated
myStopping <- StoppingMinPatients(nPatients=36)
##Now specified the design with all the above information and starting with a dose of 25
##Specified the design(for details please refer to the 'DualResponsesDesign' example)
design <- DualResponsesDesign(nextBest=mynextbest,
model=DLEmodel,
Effmodel=Effmodel,
stopping=myStopping,
increments=myIncrements,
cohortSize=mySize,
data=data,startingDose=25)
##Specify the true DLE and efficacy curves
myTruthDLE<- function(dose)
{ DLEmodel@prob(dose, phi1=-53.66584, phi2=10.50499)
}
myTruthEff<- function(dose)
{Effmodel@ExpEff(dose,theta1=-4.818429,theta2=3.653058)
}
## Then specified the simulations and generate the trial for 2 times
mySim <-simulate(object=design,
args=NULL,
trueDLE=myTruthDLE,
trueEff=myTruthEff,
trueNu=1/0.025,
nsim=2,
seed=819,
parallel=FALSE)
##Then produce a summary of your simulations
summary(mySim,
trueDLE=myTruthDLE,
trueEff=myTruthEff)
##If DLE and efficacy samples are involved
##Please refer to design-method 'simulate DualResponsesSamplesDesign' examples for details
##specified the next best
mynextbest<-NextBestMaxGainSamples(DLEDuringTrialtarget=0.35,
DLEEndOfTrialtarget=0.3,
TDderive=function(TDsamples){
quantile(TDsamples,prob=0.3)},
Gstarderive=function(Gstarsamples){
quantile(Gstarsamples,prob=0.5)})
##specified the design
design <- DualResponsesSamplesDesign(nextBest=mynextbest,
cohortSize=mySize,
startingDose=25,
model=DLEmodel,
Effmodel=Effmodel,
data=data,
stopping=myStopping,
increments=myIncrements)
##options for MCMC
##For illustration purpose, we will use 50 burn-ins to generate 200 samples
options<-McmcOptions(burnin=50,step=2,samples=200)
##The simulations
##For illustration purpose only 2 simulation is produced (nsim=2).
mySim<-simulate(design,
args=NULL,
trueDLE=myTruthDLE,
trueEff=myTruthEff,
trueNu=1/0.025,
nsim=2,
mcmcOptions=options,
seed=819,
parallel=FALSE)
##Then produce a summary of your simulations
summary(mySim,
trueDLE=myTruthDLE,
trueEff=myTruthEff)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.